Proven efficacy and tolerability

See clinical trial results of Flebogamma® DIF in: Primary immunodeficiency Autoimmune Disease

Concentration matters: consider Flebogamma® DIF 5% for your high-risk patients

Flebogamma® DIF 5% may be an appropriate choice for many of your patients, including those who cannot tolerate a 10% IVIG solution In a recent trial, only 2.2% of infusions with Flebogamma® DIF (...)

Additional resources and support for Flebogamma® DIF

PediGri®: Do you know where your IVIG comes from?

Resources

Additional resources

Tolerability Brochure

Learn more about the safety profile of Flebogamma® DIF